News Sentiment

NYXH sentiment intelligence

Nyxoah news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 53 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 1.71 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-0.6% over one week, +23.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Price to sales forward of Nyxoah SA – SWB:5YI

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction -0.6% Price digesting
Trend fit Trend inactive 23.0% over four weeks
Fair value -76.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 27
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
TradingView 5
Market source 5
Idéal Investisseur 4
Moomoo 3
GlobeNewswire 3
Investing.com 2
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 14
Analyst action 6
Deals and strategy 3
Balance sheet 2
Regulatory and legal 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 50
TradingView Direct company coverage

Price to sales forward of Nyxoah SA – SWB:5YI

This article provides a brief financial overview for Nyxoah SA (SWB:5YI), focusing on its forward price-to-sales ratio. It indicates that no trades have occurred and presents links to various financial data, news, and community sections for the company on the TradingView platform

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 01:40
Source
TradingView
Stock Titan Direct company coverage

Nyxoah (NASDAQ: NYXH) posts Q2 2026 prelims, secures $110M and sees CMS propose higher Genio reimbursement

Nyxoah (NASDAQ: NYXH) announced strong preliminary Q2 2026 results, with global net revenue expected to be €7.7 million and U.S. revenue €5.2 million, both demonstrating over 20% sequential growth. The company also secured $110 million in financing and anticipates a significant i

Tone
Positive 73/100
Event
Earnings
Published
09 Jul 2026 20:11
Source
Stock Titan
Investing.com Direct company coverage

Stifel reiterates Hold on Nyxoah stock, keeps $3 price target

Stifel has reiterated its Hold rating on Nyxoah SA stock, maintaining a $3.00 price target after the company's Investor Day. The firm expressed caution regarding Nyxoah's ambitious breakeven revenue and gross margin targets, noting that the company operates in a small market shar

Tone
Negative 37/100
Event
Earnings
Published
09 Jul 2026 20:11
Source
Investing.com
Investing.com Nigeria Direct company coverage

Stifel reiterates Hold on Nyxoah stock, keeps $3 price target By Investing.com

Stifel maintained its Hold rating and $3.00 price target for Nyxoah SA (NASDAQ:NYXH) following the company's Investor Day. The firm expressed a cautious outlook, citing limited new information, ambitious breakeven and gross margin targets, and the company's projected need for add

Tone
Negative 36/100
Event
Analyst action
Published
09 Jul 2026 19:40
Source
Investing.com Nigeria
Moomoo Direct company coverage

Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $2.85

Baird has reiterated its Hold rating on Nyxoah SA (NYXH.US) but has reduced its target price for the company's shares to $2.85. This adjustment reflects Baird's updated outlook on Nyxoah SA's financial prospects and market valuation.

Tone
Negative 31/100
Event
Analyst action
Published
09 Jul 2026 19:40
Source
Moomoo
TradingView Direct company coverage

Price to earnings forward of Nyxoah SA – SWB:5YI

This article provides a brief financial overview of Nyxoah SA (SWB:5YI), focusing on its forward price-to-earnings ratio. The content indicates the market was closed with no trades at the time of viewing. It also lists various data providers for market and reference information.

Tone
Neutral 50/100
Event
Earnings
Published
09 Jul 2026 18:11
Source
TradingView
GlobeNewswire Direct company coverage

Nyxoah Announces Preliminary Results for the Second Quarter of 2026

Nyxoah announced preliminary unaudited second-quarter 2026 financial results, reporting an expected global net revenue of €7.7 million, driven by strong U.S. launch momentum. The company saw significant growth in U.S. net revenue and commercial indicators, including increased sur

Tone
Positive 73/100
Event
Earnings
Published
08 Jul 2026 19:40
Source
GlobeNewswire
Market source Direct company coverage

Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution

Nyxoah's analyst update has reduced its fair value estimate by approximately 21%, from €7.37 to €5.80, following a recent capital raise and analyst caution. While Piper Sandler remains optimistic about the Genio product's uptake and maintains an "Overweight" rating, Stifel has lo

Tone
Negative 36/100
Event
Analyst action
Published
08 Jul 2026 09:11
Source
Market source
Moomoo Direct company coverage

Nyxoah Preliminary Q2 Revenue Rises From Q1; 2026 Outlook Reaffirmed

Nyxoah reported preliminary second-quarter revenue of €1.7 million, an increase from €1.3 million in the first quarter of 2026, driven by growth in Germany. The company reaffirmed its 2026 outlook, expecting revenue between €9 million and €12 million and maintaining its gross mar

Tone
Positive 71/100
Event
Earnings
Published
07 Jul 2026 21:10
Source
Moomoo
MSN Direct company coverage

Nyxoah reports Q2 2026 preliminary revenue of €7.7M

Nyxoah reported preliminary revenue of €7.7 million for the second quarter of 2026. This financial update provides an early look at the company's performance during the last quarter.

Tone
Positive 71/100
Event
Earnings
Published
07 Jul 2026 21:10
Source
MSN
Stock Titan Direct company coverage

Nyxoah says U.S. launch lifted Q2 revenue 21% sequentially

Nyxoah (Nasdaq:NYXH) announced preliminary, unaudited Q2 2026 results including global net revenue of €7.7 million, a 21% sequential increase, driven by U.S. revenue of €5.2 million, up 22%. The company reaffirmed its full-year 2026 revenue guidance of €36–40 million and detailed

Tone
Positive 75/100
Event
Earnings
Published
07 Jul 2026 20:10
Source
Stock Titan
Finviz Direct company coverage

NYXH - Nyxoah SA Latest SEC Filings

This article provides the latest SEC filing information for Nyxoah SA (NYXH), including its current stock performance, key financial metrics, and various valuation ratios. The data covers market capitalization, sales, earnings per share (EPS) figures, insider and institutional ow

Tone
Negative 38/100
Event
Earnings
Published
04 Jul 2026 18:10
Source
Finviz
Stock Titan Direct company coverage

Nyxoah adds 146,531 shares as voting rights reach 100.1 million

Nyxoah (Nasdaq: NYXH) has updated its share capital and voting rights as of June 30, 2026, following the issuance of 146,531 new shares from exercised restricted share units. The company's share capital is now EUR 7,075,152.31, with 100,072,815 ordinary shares and an equal number

Tone
Negative 40/100
Event
Market update
Published
01 Jul 2026 04:10
Source
Stock Titan
GlobeNewswire Direct company coverage

Information on the total number of voting rights and shares

Nyxoah SA has released updated information on its total number of voting rights and shares as of June 30, 2026. This follows the issuance of 146,531 new shares due to the exercise of restricted share units. The company reported a total of 100,072,815 voting rights and shares, alo

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 16:30
Source
GlobeNewswire
Pluang Direct company coverage

Nyxoah sees Orin Hirchman cross 10% voting rights threshold, Resmed drops below 3%.

Nyxoah SA announced that Orin Hirchman, through controlled entities, has acquired 14.55% of voting rights as of June 10, 2026, exceeding the 10% disclosure threshold. Concurrently, Resmed Inc. reduced its stake to 1.95%, falling below the 3% threshold. These shifts in significant

Tone
Neutral 50/100
Event
Deals and strategy
Published
29 Jun 2026 20:40
Source
Pluang
Stock Titan Direct company coverage

Nyxoah gets two ownership notices: AIGH at 14.55%, Resmed at 1.95%

Nyxoah (NASDAQ: NYXH) has announced two significant transparency notifications concerning major shareholdings, dated June 10, 2026. Entities controlled by Orin Hirchman, through AIGH Investment Partners, LP and WVP Emerging Manager Onshore Fund LLC - AIGH Series, now collectively

Tone
Positive 61/100
Event
Market update
Published
29 Jun 2026 20:40
Source
Stock Titan
GlobeNewswire Direct company coverage

Publication relating to transparency notifications

Nyxoah SA announced that it received two transparency notifications regarding changes in shareholdings. Orin Hirchman's controlled entities acquired voting securities, crossing the 10% threshold to hold 14.55% of shares as of June 10, 2026. Separately, Resmed Inc. reported a pass

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 20:40
Source
GlobeNewswire
TradingView Direct company coverage

Price to earnings forward of Nyxoah SA – LSX:A2QCWK

This article presents financial information for Nyxoah SA (LSX:A2QCWK), specifically its forward price-to-earnings ratio. The content primarily consists of navigation and boilerplate text from TradingView, with a placeholder for the actual "Period Value Change" data. The financia

Tone
Neutral 50/100
Event
Earnings
Published
29 Jun 2026 08:40
Source
TradingView
TradingView Direct company coverage

NYXH Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Nyxoah SA (NYXH) stock, gathering analysts' opinions on its future price, with a max estimate of 11.10 EUR and a min estimate of 2.58 EUR. It also details the company's recent financial performance, including earnings, revenue

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 14:40
Source
TradingView
Sahm Direct company coverage

Nyxoah to Host Investor Day in New York on July 8, 2026

Nyxoah SA, a medical technology company specializing in Obstructive Sleep Apnea (OSA) solutions, announced it will host an Investor and Analyst Day in New York on Wednesday, July 8, 2026. The event will take place at Bank of America's offices from 10:00 AM to 12:30 PM ET and will

Tone
Positive 72/100
Event
Analyst action
Published
25 Jun 2026 03:40
Source
Sahm
Investing.com Nigeria Direct company coverage

Form 6K Nyxoah For: 23 June By Investing.com

This article announces the filing of Form 6K by Nyxoah on June 23, 2026. It appears to be a standard financial reporting notification from Investing.com, providing basic details without further commentary or analysis within the snippet provided.

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 13:39
Source
Investing.com Nigeria
Market source Direct company coverage

Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns

Nyxoah (ENXTBR:NYXH) has seen its fair value estimate drop by 18% to €7.37 per share, following analyst cuts influenced by concerns about capital needs and execution risk. While some analysts like Piper Sandler remain optimistic about the Genio launch and revenue trends, others l

Tone
Negative 29/100
Event
Earnings
Published
24 Jun 2026 12:30
Source
Market source
Stock Titan Direct company coverage

Nyxoah lines up U.S. launch update, reimbursement talk for July 8

Nyxoah (NYXH) will host an Investor and Analyst Day in New York on July 8, 2026, to discuss the U.S. Genio launch momentum, OSA market dynamics, reimbursement strategies, and the company’s path to profitability. The event, held at Bank of America Tower, will feature Nyxoah's lead

Tone
Positive 71/100
Event
Analyst action
Published
23 Jun 2026 19:40
Source
Stock Titan
Stock Titan Direct company coverage

Nyxoah (NASDAQ: NYXH) adds $15M EIB debt and details major holders

Nyxoah (NASDAQ: NYXH) has secured a $15 million loan tranche from the European Investment Bank, bringing its total new capital raised in June 2026 to approximately $110 million. This non-dilutive debt will fund the U.S. commercial launch of its Genio sleep apnea system, alongside

Tone
Positive 70/100
Event
Balance sheet
Published
23 Jun 2026 19:40
Source
Stock Titan
Investing.com Australia Direct company coverage

Form 13G NYXOAH SA For: 22 June By Investing.com

This article reports on a Form 13G filing for NYXOAH SA on June 22. It is a brief announcement from Investing.com with no further details. The content primarily includes disclaimers about the risks of trading financial instruments and cryptocurrencies.

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 16:39
Source
Investing.com Australia
Stock Titan Direct company coverage

AIGH entities and Orin Hirschman report 14.5% stake in NYXOAH (NASDAQ: NYXH)

AIGH Capital Management LLC, AIGH Investment Partners LLC, and Orin Hirschman have jointly reported a 14.5% stake in NYXOAH (NASDAQ: NYXH), amounting to 14,534,880 shares of Common Stock. This Schedule 13G filing indicates that the reporting persons hold sole voting and dispositi

Tone
Neutral 50/100
Event
Deals and strategy
Published
22 Jun 2026 10:12
Source
Stock Titan
Quartr Direct company coverage

Nyxoah (NYXH) 44th Annual J.P. Morgan Healthcare Conference Summary

Nyxoah (NYXH) presented at the 44th Annual J.P. Morgan Healthcare Conference, highlighting the significant market opportunity in obstructive sleep apnea (OSA) and the differentiating features of its Genio system. The company discussed its successful U.S. launch post-FDA approval,

Tone
Positive 71/100
Event
Regulatory and legal
Published
21 Jun 2026 12:12
Source
Quartr